Article
Transforming pathways unleashed by a HDAC2 mutation in human cancer.
Oncogene - 26 Jun 2008
Ropero S, Ballestar E, Alaminos M, Arango D, Schwartz S, Esteller M
Abstract excerpt
Although disruption of histone modification patterns is a common hallmark of human cancer, our knowledge of the mechanistic role of histone-modifying enzymes in its generation is very limited. We have recently identified an inactivating mutation in the histone deacetylase-2 (HDAC2) in sporadic carcinomas with microsatellite instability and in tumors arising in individuals with hereditary nonpolyposis colorectal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
